HEALTHCARE

12 Mar 2020

Patient Safety Movement Foundation Appoints New Chairman; Announces Drive Toward Zero Preventable Patient Deaths By 2030

Patient Safety Movement Foundation (PSMF) – a global non-profit dedicated to unifying those involved in the healthcare ecosystem, identifying challenges that are causing patient deaths, and creating actionable solutions to mitigate them – is pleased to announce the appointment of its new chairman of the board of directors – Michael A.E. Ramsay, MD, FRCA. It also reaffirms its commitment to patient health and safety with updates to its mission, vision and values; and reestablishes its goal of achieving ZERO preventable patient deaths by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200310005733/en/......

Continue Reading

12 Mar 2020

Egypt's confirmed coronavirus cases increase to 67

Egypt has registered seven new coronavirus cases bringing the total number of confirmed cases to 67, the health ministry said on Wednesday, Reuters reports.

Of the total number, at least 45 cases have been detected"...

Continue Reading

12 Mar 2020

Vifor Pharma Group Reports Strong Growth in 2019, Exceeding Raised Guidance

Regulatory News:

Vifor Pharma Group recorded strong financial and operational performance in 2019 by focusing on its three strategic growth drivers while continuing to invest in its pipeline. The company exceeded"...

Continue Reading

11 Mar 2020

Coronavirus affecting Africa’s aviation sector, says industry association

The current coronavirus outbreak is affecting Africa’s aviation sector due to massive flight suspensions and cancellations, the industry association said on Tuesday.

Abderahmane Berthe, secretary-general"...

Continue Reading

11 Mar 2020

Takeda Provides Update on TOURMALINE-MM2 Phase 3 Trial

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the results from the TOURMALINE-MM2 study designed to evaluate the addition of NINLARO™ (ixazomib) to lenalidomide and dexamethasone in newly diagnosed transplant ineligible multiple myeloma patients. The addition of ixazomib to lenalidomide and dexamethasone resulted in an improvement in median progression-free survival (PFS) of 13.5 months (35.3 months versus 21.8 months; hazard ratio [HR] 0.83; p=0.073); however, it did not meet the threshold for statistical significance. The safety profile associated with NINLARO from the TOURMALINE-MM2......

Continue Reading

11 Mar 2020

Sinterex named Best 3D-Printed Healthcare Products Manufacturer Middle East

Global Health & Pharma (GHP), a global information sharing platform & a multi-disciplinary members community announced winners of the 2019 Technology Awards this month and recognised Sinterex as Best 3D-Printed Healthcare Products Manufacturer – Middle East.

In"...

Continue Reading

09 Mar 2020

Alexandria New Medical Center ratifies dividends

ArabFinance: Alexandria New Medical Center's (AMES) ordinary general assembly approved on the 5th of March the profit distribution for the shareholders of EGP 8,784,600.

Based on the performance of 2019, the"...

Continue Reading

09 Mar 2020

Takeda Initiates Development of a Plasma-Derived Therapy for COVID-19

Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today will share with members of the United States Congress that it is initiating the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) to treat high-risk individuals with COVID-19, while also studying whether Takeda’s currently marketed and pipeline products may be effective treatments for infected patients. SARS-CoV-2 is the virus that causes COVID-19. Hyperimmune globulins are plasma derived-therapies that have previously been shown to be effective in the treatment of severe acute viral respiratory infections and may be a treatment......

Continue Reading

08 Mar 2020

MNHD Prices 115k sqm land sale in Taj City, implies huge upside for land NAV

Madinet Nasr Housing and Development (MNHD) has announced signing a contract to sell a 114,537sqm residential plot of land in Taj City at EGP10,000/sqm and a total value of EGP1.145bn to MINKA Real Estate (MINKA), a Sallam family venture led by Abdallah Nabil Sallam.

The"...

Continue Reading

08 Mar 2020

Egg Freezing Techniques Offering Women Flexibility on Their Motherhood Timeline Become Increasingly Popular

In observance of International Women’s Day, Fakih IVF Fertility Center is rolling out a special campaign supporting all women and their choices. The campaign is running throughout March, across the center’s branches located in Abu Dhabi, Dubai and Al Ain.

With"...

Continue Reading
Found articles: - Pages  
Contact US | Powered by CNPHUB.com - All Rights Reserved